Back
Speaker illustration

Doctor Teruki Sato

Akita University Graduate School of Medicine, Akita (Japan)

Presentations

A novel APJ ligand, ELABELA/Apela/Toddler, protects from pressure overload- and Angiotensin II-induced cardiac hypertrophy and fibrosis

Event: ESC Congress 2017

Topic: Basic Science

Session: Remodelling and cardioprotection

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources